Supplementary Table S3 from Validation of Immunotherapy Response Score as predictive of pan-solid tumor anti-PD-1/PD-L1 benefit
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table S3 shows unadjusted restricted mean survival time analysis of for real-world PFS and overall survival in the monotherapy validation cohort
Authors: Benjamin J Bulen, Nickolay A Khazanov, Daniel H. Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William J. Edenfield, Elizabeth Claire Dees, Adedayo A. Onitilo, Gary L Buchschacher, Alan M Miller, Benjamin M. Parsons, Timothy R. Wassenaar, Jennifer M. Suga, Robert D Siegel, William Irvin, Suresh Nair, Jennifer N. Slim, Jamal Misleh, Jamil Khatri, Gregory A Masters, Sachdev Thomas, Malek M. Safa, Daniel M. Anderson, Jonathan Mowers, Anna C Dusenbery, Stephanie Drewery, Komal Plouffe, Travis Reeder, Hana Vakil, Lynnae Patrias, Amanda Falzetta, Ryan Hamilton, Kat Kwiatkowski, D. Bryan Johnson, Daniel R Rhodes, Scott A. Tomlins
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4382937570